KDR and type 2 diabetes mellitus: Although a previous study in 28 subjects demonstrated an increase of EPCs by multifactorial treatment in patients with type 2 diabetes as assessed by an in-vitro culture assay[12], we were not able to reproduce this finding when measuring CD133/VEGF-R2+ cells by FACS analysis.